Image

Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and Nonbinary Young Adults

Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and Nonbinary Young Adults

Recruiting
18-25 years
All
Phase N/A

Powered by AI

Overview

The goal of this single-arm feasibility study is to evaluate the feasibility and acceptability of an 8-week mindful self-compassion intervention and associated data-collection plan among transgender and nonbinary young adults. Participants will be asked to:

  • Complete weekly 2.5-hour virtual classes for 8 weeks and a 4-hour virtual retreat
  • Practice specific activities in between classes for 20-30 minutes a day
  • Answer survey questions before starting the intervention, half-way through the intervention, after the intervention, and 3-months after the intervention ends.

Description

The specific aims of this study are to: 1) evaluate the feasibility and acceptability of an 8-week Mindful Self-Compassion (MSC) intervention and data collection plan (pre-, post-, 3-month follow-up) with 5 consecutive groups of transgender and nonbinary young adults (TNYA), 2) evaluate the usability of MSC intervention activities by TNYA and determine whether MSC activities need to be tailored for TNYA, and 3) explore data collected throughout each intervention implementation to evaluate patterns of missingness and potential participant burden, intervention adherence, and reasons for dropout.

Eligibility

Inclusion Criteria:

  • transgender, nonbinary, genderqueer (or another non-cisgender identity)
  • have reliable access to a smart phone or computer/tablet and the Internet and is reasonably able to make the time commitment required of the program (self-report)
  • speak and understand English

Exclusion Criteria:

  • has had formal mindfulness training (i.e. mindfulness-based stress reduction course) or engages in regular mindfulness practice (15 minutes more than twice a week for the last six months or more)
  • Score 15 or higher on the patient health questionnaire-8 (PHQ-8)
  • Score 2 or higher on the Columbia Suicide Severity Rating Scale
  • Experienced an acute physical health crisis (e.g., chemotherapy, recovery from severe injury) (Germer & Neff, 2019, p. 80) in the past year
  • Head trauma, seizure, or loss of consciousness in the past 6 months
  • Reports a history of trauma AND Scores 14 or higher on Post-Traumatic Checklist, 6-item Civilian version
  • Reports a diagnosis of a personality disorder
  • Reports a diagnosis of schizophrenia or a history of psychosis
  • Reports acute panic attack in the past month and history of acute panic attacks with concern/worry about having another one in the future OR Reports severe social anxiety which would make attending class too difficult
  • Reports an acute episode of psychosis or suicide attempt in the past 12 months
  • Has engaged in non-suicidal self-injury in the past 6 months
  • Currently prescribed antipsychotic medications, benzodiazepine (equivalent to 30mg diazepam/day) or opioids (>40mg morphine equivalent/day)
  • Prescribed any other psychiatric medication, including medication for opioid use disorder, whose dose has been changed in the past 8 weeks or is anticipated to change in the next 6 months.
  • Currently engage in harmful drinking (5 or more drinks on one occasion (Flentje et al., 2020) more than once in the past 2 weeks; OR have any concerns about the expectation to not be using substances during group sessions
  • has undergone detoxification from alcohol or other drugs and has been in sustained remission (with or without medication) for less than 1 year
  • Has been hospitalized overnight for mental health related reasons in the past year (any diagnoses except bipolar disorder) OR have a diagnosis of bipolar disorder and have had an episode of mania or have been hospitalized in the past 2 years
  • Reports any other acute physical or mental illness symptoms that may make group participation difficult

Study details
    Healthy

NCT06409975

University of Rhode Island

4 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.